Biotechnology therapeutics company developing topical cyclic-peptide eye drops to treat retinal microvascular diseases, including diabetic retinopathy, diabetic macular edema, and age-related macular degeneration
Biotechnology therapeutics company developing topical cyclic-peptide eye drops to treat retinal microvascular diseases, including diabetic retinopathy, diabetic macular edema, and age-related macular degeneration. Its anti-angiogenic and anti-inflammatory approach aims to stabilize retinal blood vessels and reduce vascular permeability, offering a non-invasive alternative to intravitreal injections.